Showing results (11-20 of 149) with videos related to
Sort By:
Pageof 15
Expert Review of Hematology|January 11, 2020
Is outcome of older people with acute myeloid leukemia improving with new therapeutic approaches and stem cell transplantation?Felicetto Ferrara, Alessandra PicardiClinical Drug Investigation|December 18, 2007
Cost-effectiveness analysis of the addition of rituximab to CHOP in young patients with good-prognosis diffuse large-B-cell lymphomaFelicetto Ferrara, Roberto RavasioHematological Oncology|April 3, 2019
Induction therapy in acute myeloid leukemia: Is it time to put aside standard 3 + 7?Felicetto Ferrara, Orsola VitaglianoHaematologica|March 1, 2002
Acute myeloid leukemia with t(8;21)/AML1/ETO: a distinct biological and clinical entityFelicetto Ferrara, Luigi Del VecchioLancet (London, England)|February 13, 2013
Acute myeloid leukaemia in adultsFelicetto Ferrara, Charles A SchifferCurrent Opinion in Oncology|October 11, 2023
Fms -like tyrosine kinase 3 positive acute myeloid leukemiaAlessandro Isidori, Giuseppe Visani, Felicetto FerraraExpert Opinion on Pharmacotherapy|August 5, 2021
Drug treatment options for acute promyelocytic leukemiaFelicetto Ferrara, Matteo Molica, Massimo BernardiCritical Reviews in Oncology/Hematology|November 13, 2007
Clinically useful prognostic factors in acute myeloid leukemiaFelicetto Ferrara, Salvatore Palmieri, Franco LeoniHaematologica|September 2, 2004
Prognostic factors and therapeutic options for relapsed or refractory acute myeloid leukemiaFelicetto Ferrara, Salvatore Palmieri, Giuseppina MeleJournal of Clinical Medicine|November 9, 2024
Evaluating Fitness in Older Acute Myeloid Leukemia Patients: Balancing Therapy and Treatment RisksMatteo Molica, Martina Canichella, Elias Jabbour, et al.Pageof 15